SVB Leerink Downgrades ChemoCentryx (CCXI) to Market Perform
Tweet
Share
E-mailGet Alerts CCXI Hot Sheet
Price: $51.99 --0%
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 31
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 31
Join SI Premium – FREE
SVB Leerink analyst Joseph Schwartz downgraded ChemoCentryx (NASDAQ: CCXI) from Outperform to Market Perform with a price target of $52.00 (from $64.00).
For an analyst ratings summary and ratings history on ChemoCentryx click here. For more ratings news on ChemoCentryx click here.
Shares of ChemoCentryx closed at $50.43 yesterday.
You May Also Be Interested In
- Gordon Haskett Downgrades Macy's (M) to Hold (3)
- Goldman Sachs Resumes Playtika Holding Corp. (PLTK) at Neutral
- LPL Investment (LPLA) PT Lowered to $240 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
